4.6 Article

Considerations for simultaneous testing of COVID-19 and tuberculosis in high-burden countries

Related references

Note: Only part of the references are listed.
Article Immunology

Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa

Andrew Boulle et al.

Summary: In South Africa, living with HIV and having current tuberculosis were independently associated with increased COVID-19 mortality. These findings highlight the impact of these two diseases on COVID-19 risk and demonstrate the associations between age, sex, and other comorbidities with COVID-19 mortality.

CLINICAL INFECTIOUS DISEASES (2021)

Review Biochemistry & Molecular Biology

Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis

Radha Gopalaswamy et al.

Summary: COVID-19 and TB are two distinct respiratory infectious diseases with similar clinical symptoms, adding to the disease burden globally and influencing host immunity. Individuals with latent TB infection (LTBI) may face the risk of TB reactivation when undergoing corticosteroid therapy for COVID-19.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Infectious Diseases

Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19

Karla Therese L. Sy et al.

INFECTIOUS DISEASES (2020)